Impact of the 1st Wave of the COVID-19 Pandemic and Lockdown on In Utero Transfer Activity in the Paris Area, France
Abstract
:1. Introduction
- -
- the proportion of successful in utero transfers, overall and by indication for in utero transfer requests;
- -
- the proportion of outborn deliveries.
2. Materials and Methods
2.1. Setting
- -
- Type III maternity hospitals have a neonatal intensive care unit and are able to receive newborns as soon as the viability threshold is reached.
- -
- Type IIA maternity hospitals have a neonatal unit and are able to care for newborns from 32 weeks of age with a birth weight of at least 1500 g.
- -
- Type IIB maternity hospitals are similar to type IIA, with an intensive care facility.
- -
- Type I maternity hospitals can accommodate healthy newborns from 37 weeks onwards.
2.2. Study Design
- -
- “lockdown period”: All pregnant women, from the Paris region, for whom a request for in utero transfer to the Ile-de-France transfer unit was made during the first lockdown in France (from 17 March to 10 May 2020).
- -
- “mirror period”: All pregnant women, from the Paris region, for whom a request for in utero transfer to the transfer unit was made during a mirror period (17 March to 10 May to overcome seasonality in births) for the years 2016, 2017, 2018 and 2019.
2.3. Data Collection
2.4. Statistical Analysis
2.5. Ethical Approval
3. Results
3.1. Overall Number of Transfer Requests and Study Population
3.2. Changes in the Indications for In Utero Transfer Request
3.3. Transfer Acceptance
3.4. Outcomes after Transfer
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
Department | 2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|---|
75 | 42,440 | 42,222 | 42,798 | 42,827 | 40,979 |
78 | 16,924 | 16,534 | 16,484 | 16,269 | 15,820 |
77 | 14,201 | 14,157 | 13,849 | 14,107 | 13,779 |
91 | 15,553 | 15,315 | 15,040 | 14,633 | 14,311 |
92 | 26,832 | 25,449 | 25,760 | 25,605 | 24,261 |
93 | 25,430 | 24,924 | 24,380 | 23,995 | 22,854 |
94 | 20,069 | 20,367 | 19,721 | 19,982 | 19,479 |
95 | 19,219 | 19,454 | 19,368 | 19,499 | 19,100 |
Total | 182,684 | 180,439 | 179,418 | 178,936 | 172,603 |
Model 1 | Model 2 1 | |||||||
---|---|---|---|---|---|---|---|---|
Years | N | IRR | 95% CI | p-Value | N | IRR | 95% CI | p-Value |
2020 | 206 | ref | — | 190 | — | — | ||
2016 | 227 | 1.10 | (0.91, 1.33) | 0.31 | 227 | 1.19 | (0.99, 1.45) | 0.07 |
2017 | 236 | 1.15 | (0.95, 1.38) | 0.15 | 236 | 1.24 | (1.03, 1.50) | 0.03 |
2018 | 204 | 0.99 | (0.82, 1.20) | 0.92 | 204 | 1.07 | (0.88, 1.31) | 0.48 |
2019 | 228 | 1.11 | (0.92, 1.34) | 0.29 | 228 | 1.20 | (0.99, 1.46) | 0.06 |
Years | N | IRR | 95% CI | p-Value |
---|---|---|---|---|
Preterm premature rupture of membranes | ||||
2020 | 56 | ref | — | |
2016 | 56 | 1.00 | 0.69, 1.45 | >0.99 |
2017 | 51 | 0.91 | 0.62, 1.33 | 0.63 |
2018 | 51 | 0.91 | 0.62, 1.33 | 0.63 |
2019 | 46 | 0.84 | 0.57, 1.24 | 0.38 |
Threat of premature delivery | ||||
2020 | 76 | ref | — | |
2016 | 93 | 1.22 | 0.90, 1.66 | 0.19 |
2017 | 107 | 1.41 | 1.05, 1.89 | 0.02 |
2018 | 89 | 1.17 | 0.86, 1.59 | 0.31 |
2019 | 111 | 1.46 | 1.09, 1.96 | 0.01 |
Pre-eclampsia, hypertension or HELLP syndrome | ||||
2020 | 34 | ref | — | |
2016 | 42 | 1.24 | 0.79, 1.95 | 0.36 |
2017 | 34 | 1.00 | 0.62, 1.61 | >0.99 |
2018 | 28 | 0.82 | 0.50, 1.36 | 0.45 |
2019 | 32 | 0.94 | 0.58, 1.53 | 0.81 |
Metrorrhagia | ||||
2020 | 9 | ref | — | |
2016 | 9 | 1.00 | 0.39, 2.56 | >0.99 |
2017 | 9 | 1.00 | 0.39, 2.56 | >0.99 |
2018 | 7 | 0.78 | 0.28, 2.09 | 0.62 |
2019 | 16 | 1.78 | 0.80, 4.20 | 0.17 |
Fetal growth restriction | ||||
2020 | 7 | ref | — | |
2016 | 17 | 2.43 | 1.05, 6.28 | 0.05 |
2017 | 18 | 2.57 | 1.12, 6.62 | 0.03 |
2018 | 21 | 3.00 | 1.34, 7.62 | 0.01 |
2019 | 12 | 1.71 | 0.69, 4.61 | 0.26 |
Other reason | ||||
2020 | 8 * | ref | — | |
2016 | 10 | 0.42 | 0.19, 0.85 | 0.64 |
2017 | 17 | 0.71 | 0.37, 1.31 | 0.08 |
2018 | 8 | 0.33 | 0.14, 0.71 | >0.99 |
2019 | 10 | 0.42 | 0.19, 0.85 | 0.64 |
Univariate Analysis | Multivariate Analysis | |||||
---|---|---|---|---|---|---|
Characteristics | OR | 95% CI | p-Value | OR | 95% CI | p-Value |
A. Threat of premature delivery | ||||||
Year, May-March lockdown 2020 vs. mirror period in 2016 to 2019 | 0.70 | (0.47–1.02) | 0.06 | 0.69 | (0.46–1.03) | 0.07 |
Age, years | 0.94 | (0.91–0.96) | <0.001 | 0.93 | (0.90–0.96) | <0.001 |
Multiple pregnancy | 1.89 | (1.21–2.96) | 0.005 | 2.43 | (1.52–3.90) | <0.001 |
History of birth weight < 1500 g or premature delivery | 1.07 | (0.61–1.88) | 0.82 | 1.05 | (0.56–1.95) | 0.88 |
History of pre-eclampsia | 1.28 | (0.33–5.00) | 0.72 | 1.59 | (0.29–8.69) | 0.59 |
History of late miscarriage or pregnancy with cervical cerclage | 1.37 | (0.71–2.66) | 0.35 | 1.57 | (0.79–3.12) | 0.20 |
B. Pre-eclampsia, hypertension, HELLP syndrome | ||||||
Year, May-March lockdown 2020 vs. mirror period in 2016 to 2019 | 0.92 | (0.57–1.48) | 0.72 | 0.88 | (0.53–1.46) | 0.63 |
Age, years | 0.99 | (0.95–1.02) | 0.44 | 0.99 | (0.96–1.03) | 0.63 |
Multiple pregnancy | 0.45 | (0.21–0.97) | 0.04 | 0.44 | (0.20–0.10) | 0.05 |
History of birth weight < 1500 g or premature delivery | 1.34 | (0.68–2.64) | 0.40 | 0.29 | (0.10–0.86) | 0.25 |
History of pre-eclampsia | 12.0 | (3.52–40.9) | <0.001 | 43.6 | (7.80–244) | <0.001 |
History of late miscarriage or pregnancy with cervical cerclage | 0.22 | (0.05–1.01) | 0.05 | 0.26 | (0.06–1.17) | 0.78 |
C. Metrorrhagia | ||||||
Year, May-March lockdown 2020 vs. mirror period in 2016 to 2019 | 0.80 | (0.37–1.75) | 0.58 | 0.71 | (0.31–1.63) | 0.42 |
Age, years | 1.04 | (0.99–1.10) | 0.15 | 1.05 | (0.99–1.10) | 0.11 |
Multiple pregnancy | 0.52 | (0.15–1.78) | 0.30 | 0.46 | (0.13–1.60) | 0.22 |
History of birth weight < 1500 g or premature delivery | 0.77 | (0.22–2.70) | 0.68 | 0.38 | (0.007–2.23) | 0.29 |
History of pre-eclampsia | 1.80 | (0.18–17.7) | 0.61 | 5.61 | (0.35–90.0) | 0.22 |
History of late miscarriage or pregnancy with cervical cerclage | 0.39 | (0.05–3.07) | 0.37 | 0.38 | (0.05–3.05) | 0.37 |
D. Fetal growth restriction | ||||||
Year, May-March lockdown 2020 vs. mirror period in 2016 to 2019 | 0.6 | (0.16–0.87) | 0.02 | 0.37 | (0.16–0.85) | 0.02 |
Age, years | 1.01 | (0.96–1.05) | 0.72 | 1.02 | (0.97–1.07) | 0.48 |
Multiple pregnancy | 0.97 | (0.42–2.21) | 0.93 | 0.96 | (0.41–2.25) | 0.93 |
History of birth weight < 1500 g or premature delivery | 1.43 | (0.60–3.40) | 0.41 | 0.84 | (0.27–2.60) | 0.76 |
History of pre-eclampsia | 6.13 | (1.43–26.3) | 0.02 | 10.3 | (1.51–69.5) | 0.02 |
History of late miscarriage or pregnancy with cervical cerclage | 0.26 | (0.03–2.01) | 0.20 | 0.24 | (0.03–1.91) | 0.18 |
Other reason (excluding COVID-19) | ||||||
Year, May-March lockdown 2020 vs. mirror period in 2016 to 2019 | 0.65 | (0.29–1.46) | 0.30 | 0.64 | (0.27–1.52) | 0.31 |
Age, years | 0.93 | (0.88–0.98) | 0.004 | 0.94 | (0.88–0.99) | 0.02 |
Multiple pregnancy | 0.48 | (0.14–1.63) | 0.24 | 0.60 | (0.17–2.10) | 0.43 |
History of birth weight < 1500 g or premature delivery | 1.31 | (0.47–3.68) | 0.61 | 0.75 | (0.20–2.81) | 0.67 |
History of pre-eclampsia | 9.00 | (2.08–38.9) | 0.003 | 9.87 | (1.19–81.8) | 0.03 |
History of late miscarriage or pregnancy with cervical cerclage | 0.36 | (0.05–2.83) | 0.33 | 0.40 | (0.05–3.16) | 0.38 |
References
- Adresse Aux Français, 16 Mars 2020. Available online: https://www.elysee.fr/emmanuel-macron/2020/03/16/adresse-aux-francais-covid19 (accessed on 20 August 2021).
- Davin-Casalena, B.; Jardin, M.; Guerrera, H.; Mabille, J.; Tréhard, H.; Lapalus, D.; Ménager, C.; Nauleau, S.; Cassaro, V.; Verger, P.; et al. L’impact de l’épidémie de COVID-19 Sur Les Soins de Premier Recours En Région Provence-Alpes-Côte d’Azur: Retour d’expérience Sur La Mise En Place d’un Dispositif de Surveillance En Temps Réel à Partir Des Données Régionales de l’Assurance Maladie. Rev. Epidemiol. Sante Publique 2021, 69, 105–115. [Google Scholar] [CrossRef] [PubMed]
- Vivanti, A.J.; Deruelle, P.; Picone, O.; Guillaume, S.; Roze, J.-C.; Mulin, B.; Kochert, F.; De Beco, I.; Mahut, S.; Gantois, A.; et al. Follow-up for Pregnant Women during the COVID-19 Pandemic: French National Authority for Health Recommendations. J. Gynecol. Obstet. Hum. Reprod. 2020, 49, 101804. [Google Scholar] [CrossRef] [PubMed]
- Vivanti, A.J.; Deruelle, P.; Picone, O.; Guillaume, S.; Roze, J.-C.; Mulin, B.; Kochert, F.; De Beco, I.; Mahu, S.; Gantois, A.; et al. Post-Natal Follow-up for Women and Neonates during the COVID-19 Pandemic: French National Authority for Health Recommendations. J. Gynecol. Obstet. Hum. Reprod. 2020, 49, 101805. [Google Scholar] [CrossRef] [PubMed]
- Athiel, Y.; Civadier, M.-S.; Luton, D.; Ceccaldi, P.-F.; Bourret, A.; Sroussi, J.; Mandelbrot, L.; Ville, Y.; Nizard, J.; Sibony, O.; et al. Impact of the Outbreak of SARS-CoV-2 Infection on Urgent Gynecological Care. J. Gynecol. Obstet. Hum. Reprod. 2020, 49, 101841. [Google Scholar] [CrossRef]
- Philip, R.K.; Purtill, H.; Reidy, E.; Daly, M.; Imcha, M.; McGrath, D.; O’Connell, N.H.; Dunne, C.P. Unprecedented Reduction in Births of Very Low Birthweight (VLBW) and Extremely Low Birthweight (ELBW) Infants during the COVID-19 Lockdown in Ireland: A ‘Natural Experiment’ Allowing Analysis of Data from the Prior Two Decades. BMJ Glob. Health 2020, 5, e003075. [Google Scholar] [CrossRef]
- Vivanti, A.J.; Mattern, J.; Vauloup-Fellous, C.; Jani, J.; Rigonnot, L.; El Hachem, L.; Le Gouez, A.; Desconclois, C.; Ben M’Barek, I.; Sibiude, J.; et al. Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France. Emerg. Infect. Dis. 2020, 26, 2069–2076. [Google Scholar] [CrossRef]
- Lasswell, S.M.; Barfield, W.D.; Rochat, R.W.; Blackmon, L. Perinatal Regionalization for Very Low-Birth-Weight and Very Preterm Infants: A Meta-Analysis. JAMA 2010, 304, 992–1000. [Google Scholar] [CrossRef]
- Chien, L.-Y.; Whyte, R.; Aziz, K.; Thiessen, P.; Matthew, D.; Lee, S.K. Improved Outcome of Preterm Infants When Delivered in Tertiary Care Centers22Canadian Neonatal Network Coordinating Centre Staff (Vancouver, BC): Li-Yin Chien, MPH, ScD.; Joanna Sale, MSc; Herbert Chan, MSc; and Shawn Stewart. Obstet. Gynecol. 2001, 98, 247–252. [Google Scholar] [CrossRef]
- Caniglia, E.C.; Magosi, L.E.; Zash, R.; Diseko, M.; Mayondi, G.; Mabuta, J.; Powis, K.; Dryden-Peterson, S.; Mosepele, M.; Luckett, R.; et al. Modest Reduction in Adverse Birth Outcomes Following the COVID-19 Lockdown. Am. J. Obstet. Gynecol. 2021, 224, 615.e1–615.e12. [Google Scholar] [CrossRef] [PubMed]
- Cheung, P.-Y.; Alshaikh, B.; Yang, C. COVID-19 Pandemic: Different Associative Relationships of City Lockdown With Preterm Births in Three Cities—An Ecological Study. Front. Pediatr. 2021, 9, 644771. [Google Scholar] [CrossRef]
- Cuestas, E.; Gómez-Flores, M.E.; Charras, M.D.; Peyrano, A.J.; Montenegro, C.; Sosa-Boye, I.; Burgos, V.; Giusti, G.; Espósito, M.; Blanco-Pool, S.S.; et al. Association between COVID-19 Mandatory Lockdown and Decreased Incidence of Preterm Births and Neonatal Mortality. J. Perinatol. 2021, 41, 2566–2569. [Google Scholar] [CrossRef] [PubMed]
- Curtis, M.D.; Villani, L.; Polo, A. Increase of Stillbirth and Decrease of Late Preterm Infants during the COVID-19 Pandemic Lockdown. Arch. Dis. Child.—Fetal Neonatal Ed. 2021, 106, 456. [Google Scholar] [CrossRef] [PubMed]
- Dong, M.; Qian, R.; Wang, J.; Fan, J.; Ye, Y.; Zhou, H.; Win, B.; Reid, E.; Zheng, S.; Lv, Y.; et al. Associations of COVID-19 Lockdown with Gestational Length and Preterm Birth in China. BMC Pregnancy Childbirth 2021, 21, 795. [Google Scholar] [CrossRef] [PubMed]
- Einarsdóttir, K.; Swift, E.M.; Zoega, H. Changes in Obstetric Interventions and Preterm Birth during COVID-19: A Nationwide Study from Iceland. Acta Obstet. Gynecol. Scand. 2021, 100, 1924–1930. [Google Scholar] [CrossRef]
- Gallo, L.A.; Gallo, T.F.; Borg, D.J.; Moritz, K.M.; Clifton, V.L.; Kumar, S. A Decline in Planned, but Not Spontaneous, Preterm Birth Rates in a Large Australian Tertiary Maternity Centre during COVID-19 Mitigation Measures. Aust. N. Z. J. Obstet. Gynaecol. 2022, 62, 62–70. [Google Scholar] [CrossRef] [PubMed]
- Graff, I.; De Broucker, C.; Vargas, J.; Vanoost, A.; Gondry, J.; Foulon, A. COVID-19 et Confinement: Impact Sur Les Complications de La Grossesse. Gynecol. Obstet. Fertil. Senol. 2021, 50, 236–239. [Google Scholar] [CrossRef] [PubMed]
- Hedermann, G.; Hedley, P.L.; Bækvad-Hansen, M.; Hjalgrim, H.; Rostgaard, K.; Poorisrisak, P.; Breindahl, M.; Melbye, M.; Hougaard, D.M.; Christiansen, M.; et al. Danish Premature Birth Rates during the COVID-19 Lockdown. Arch. Dis. Child.-Fetal Neonatal Ed. 2021, 106, 93–95. [Google Scholar] [CrossRef] [PubMed]
- Hedley, P.L.; Hedermann, G.; Hagen, C.M.; Bækvad-Hansen, M.; Hjalgrim, H.; Rostgaard, K.; Laksafoss, A.D.; Hoffmann, S.; Jensen, J.S.; Breindahl, M.; et al. Preterm Birth, Stillbirth and Early Neonatal Mortality during the Danish COVID-19 Lockdown. Eur. J. Pediatr. 2021, 181, 1175–1184. [Google Scholar] [CrossRef]
- Huseynova, R.; Bin Mahmoud, L.; Abdelrahim, A.; Al Hemaid, M.; Almuhaini, M.S.; Jaganathan, P.P.; Career, H.; Huseynov, O. Prevalence of Preterm Birth Rate During COVID-19 Lockdown in a Tertiary Care Hospital, Riyadh. Cureus 2021, 13, e13634. [Google Scholar] [CrossRef]
- Kirchengast, S.; Hartmann, B. Pregnancy Outcome during the First COVID 19 Lockdown in Vienna, Austria. Int. J. Environ. Res. Public Health 2021, 18, 3782. [Google Scholar] [CrossRef]
- Klumper, J.; Kazemier, B.M.; Been, J.V.; Bloemenkamp, K.W.M.; de Boer, M.A.; Erwich, J.J.H.M.; Heidema, W.; Klumper, F.J.C.M.; Bijvank, S.W.A.N.; Oei, S.G.; et al. Association between COVID-19 Lockdown Measures and the Incidence of Iatrogenic versus Spontaneous Very Preterm Births in the Netherlands: A Retrospective Study. BMC Pregnancy Childbirth 2021, 21, 767. [Google Scholar] [CrossRef] [PubMed]
- Leibovitch, L.; Reichman, B.; Mimouni, F.; Zaslavsky-Paltiel, I.; Lerner-Geva, L.; Wasserteil, N.; Sagiv, N.; Daas, S.; Almashanu, S.; Strauss, T. Preterm Singleton Birth Rate during the COVID-19 Lockdown: A Population-Based Study. Am. J. Perinatol. 2021, 39, 1020–1026. [Google Scholar] [CrossRef]
- Matheson, A.; McGannon, C.J.; Malhotra, A.; Palmer, K.R.; Stewart, A.E.; Wallace, E.M.; Mol, B.W.; Hodges, R.J.; Rolnik, D.L. Prematurity Rates During the Coronavirus Disease 2019 (COVID-19) Pandemic Lockdown in Melbourne, Australia. Obstet. Gynecol. 2021, 137, 405–407. [Google Scholar] [CrossRef] [PubMed]
- Molina-Merino, A.; Martínez-Rodríguez, L.; Cubells-García, E.; Hortelano-Platero, V.; Estañ-Capell, J. Effect of Lockdown on the Preterm Births in a Valencian Comunity. An. Pediatría Engl. Ed. 2021, 95, 379–381. [Google Scholar] [CrossRef]
- Muin, D.A.; Neururer, S.; Falcone, V.; Windsperger, K.; Helmer, H.; Leitner, H.; Kiss, H.; Farr, A. Antepartum Stillbirth Rates during the COVID-19 Pandemic in Austria: A Population-Based Study. Int. J. Gynecol. Obstet. 2022, 156, 459–465. [Google Scholar] [CrossRef]
- Ranjbar, F.; Allahqoli, L.; Ahmadi, S.; Mousavi, R.; Gharacheh, M.; Eshraghi, N.; Alkatout, I. Changes in Pregnancy Outcomes during the COVID-19 Lockdown in Iran. BMC Pregnancy Childbirth 2021, 21, 577. [Google Scholar] [CrossRef]
- Rolnik, D.L.; Matheson, A.; Liu, Y.; Chu, S.; Mcgannon, C.; Mulcahy, B.; Malhotra, A.; Palmer, K.R.; Hodges, R.J.; Mol, B.W. Impact of COVID-19 Pandemic Restrictions on Pregnancy Duration and Outcome in Melbourne, Australia. Ultrasound. Obstet. Gynecol. 2021, 58, 677–687. [Google Scholar] [CrossRef]
- Yalçin, S.S.; Boran, P.; Tezel, B.; Şahlar, T.E.; Özdemir, P.; Keskinkiliç, B.; Kara, F. Effects of the COVID-19 Pandemic on Perinatal Outcomes: A Retrospective Cohort Study from Turkey. BMC Pregnancy Childbirth 2022, 22, 51. [Google Scholar] [CrossRef] [PubMed]
- Galle, A.; Semaan, A.; Huysmans, E.; Audet, C.; Asefa, A.; Delvaux, T.; Afolabi, B.B.; Ayadi, A.M.E.; Benova, L. A Double-Edged Sword—Telemedicine for Maternal Care during COVID-19: Findings from a Global Mixed-Methods Study of Healthcare Providers. BMJ Global. Health 2021, 6, e004575. [Google Scholar] [CrossRef]
- Assistance Publique–Hôpitaux de Paris’ Response to the COVID-19 Pandemic. Lancet 2020, 395, 1760–1761. [CrossRef]
- Justman, N.; Shahak, G.; Gutzeit, O.; Ben Zvi, D.; Ginsberg, Y.; Solt, I.; Vitner, D.; Beloosesky, R.; Weiner, Z.; Zipori, Y. Lockdown with a Price: The Impact of the COVID-19 Pandemic on Prenatal Care and Perinatal Outcomes in a Tertiary Care Center. Isr. Med. Assoc. J. 2020, 22, 533–537. [Google Scholar] [PubMed]
- Zarasvand, S.; Bayar, E.; Adan, M.; Mountain, K.; Lewis, H.; Joash, K.; Teoh, T.; Bennett, P.R.; Das, S.; Sykes, L. Rapid Quality Improvement in a Preterm Birth Clinic Care Pathway during the COVID-19 Pandemic. BMJ Open Qual. 2020, 9, e001049. [Google Scholar] [CrossRef] [PubMed]
- Barg, M.; Rotem, R.; Mor, P.; Rottenstreich, M.; Khatib, F.; Grisaru-Granovsky, S.; Armon, S. Delayed Presentation of Ectopic Pregnancy during the COVID-19 Pandemic: A Retrospective Study of a Collateral Effect. Int. J. Gynecol. Obstet. 2021, 153, 457–461. [Google Scholar] [CrossRef]
- Dvash, S.; Cuckle, H.; Smorgick, N.; Vaknin, Z.; Padoa, A.; Maymon, R. Increase Rate of Ruptured Tubal Ectopic Pregnancy during the COVID-19 Pandemic. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021, 259, 95–99. [Google Scholar] [CrossRef] [PubMed]
- Taux de Natalité et Âge Moyen de La Mère à La Naissance En 2020, et Nombre de Naissances En 2019 | Insee. Available online: https://www.insee.fr/fr/statistiques/2012761#titre-bloc-3 (accessed on 13 February 2022).
“Mirror Period” 17 March–10 May 2016–2019 (n = 895) | “Lockdown Period” 17 March–10 May 2020 (n = 206) | p-Value | |
---|---|---|---|
Maternal characteristics | |||
Age (years); mean (SD) | 30.9 (5.8) | 32.1 (5.6) | 0.002 |
Parity; mean (SD) | 1.4 (1.0) | 1.5 (1.0) | 0.042 |
ART; n (%) | 89 (10) | 16 (7.8) | 0.34 |
Multiple pregnancy; n (%) | 112 (13) | 31 (15) | 0.34 |
Antihypertensive drug use; n (%) | 174 (19) | 32 (16) | 0.19 |
Tocolysis use; n (%) | 438 (49) | 91 (44) | 0.22 |
Cervical cerclage; n (%) | 29 (3) | 5 (2) | 0.54 |
History of preterm delivery or late miscarriage; n (%) | 38 (4) | 7 (3) | 0.58 |
Gestational age at the time of in utero transfer request | 0.72 | ||
<24 weeks; n (%) | 29 (3) | 6 (3) | |
[24–276/7[; n (%) | 247 (28) | 58 (28) | |
[28–316/7[; n (%) | 389 (43) | 82 (40) | |
[32–376/7[; n (%) | 230 (26) | 60 (29) | |
Indication for in utero transfer request | 0.001 | ||
PPROM; n (%) | 205 (23) | 56 (27) | |
Threatened preterm birth; n (%) | 400 (45) | 76 (37) | |
Pregnancy-related vascular complication; n (%) | 136 (15) | 34 (17) | |
Metrorrhagia; n (%) | 41 (5) | 9 (4) | |
Fetal growth restriction; n (%) | 68 (8) | 7 (3) | |
Other reason; n (%) | 45 (5) | 24 (12) * | |
Level of maternity unit requesting in utero transfer | 0.57 | ||
Level I; n (%) | 164 (18) | 36 (18) | |
Level IIA; n (%) | 320 (36) | 67 (33) | |
Level IIB; n (%) | 353 (39) | 92 (45) | |
Level III; n (%) £ | 53 (6) | 10 (5) |
“Control” Group 17 March–10 May 2016–2019 (n = 895) | “Lockdown” Group 17 March–10 May 2020 (n = 206) | p-Value | |
---|---|---|---|
Transfer acceptance, overall; n (%) £ | 781 (87) | 174 (84) | 0.29 |
Transfer acceptance, by indication; effective transfer/transfer requests (%) | |||
PPROM | 182/205 (89) | 49/56 (88) | 0.79 |
Threatened preterm birth | 353/400 (88) | 63/76 (83) | 0.20 |
Pregnancy-related vascular complication | 122/136 (90) | 31/34 (91) | >0.99 |
Metrorrhagia | 36/41 (88) | 8/9 (89) | >0.99 |
Fetal growth restriction | 57/68 (84) | 4/7 (57) | 0.12 |
Severe COVID-19 | - | 15/16 (94) | - |
Other reason | 31/45 (69) | 4/8 (50) | 0.42 |
Cancellation; n (%) £ | 114 (13) | 32 (16) | |
Level of maternity hospital receiving in utero transfer | 0.51 | ||
Level I; n (%) | 1 (0) | 0 (0) | |
Level IIA; n (%) | 37 (5) | 10 (6) | |
Level IIB; n (%) | 154 (20) | 41 (24) | |
Level III; n (%) | 589 (75) | 123 (71) | |
Outborn births; n (%) | 38 (4) | 7 (3) | 0.58 |
Univariate Model | Multivariate Model 1 | Multivariate Model 2 | |||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p-Value | OR | 95% CI | p-Value | OR | 95% CI | p-Value | |
Characteristic | |||||||||
Year, May–March lockdown 2020 vs. mirror period in 2016 to 2019 | 0.75 | (0.49–1.17) | 0.19 | 0.77 | (0.49–1.25) | 0.27 | 0.76 | (0.48–1.23) | 0.25 |
Primary reason for transfer request | |||||||||
Preterm premature rupture of membranes | - | - | - | - | - | - | |||
Threat of premature delivery | 0.90 | (0.56–1.43) | 0.66 | 0.92 | (0.56–1.48) | 0.73 | 0.69 | (0.39–1.20) | 0.19 |
Pre-eclampsia, hypertension, HELLP syndrome | 1.17 | (0.63–2.23) | 0.63 | 1.15 | (0.61–2.25) | 0.68 | 1.25 | (0.65–2.48) | 0.51 |
Metrorrhagia | 0.95 | (0.40–2.66) | 0.92 | 0.93 | (0.38–2.63) | 0.88 | 0.76 | (0.30–2.18) | 0.57 |
Fetal growth restriction | 0.57 | (0.29–1.16) | 0.11 | 0.52 | (0.26–1.09) | 0.07 | 0.58 | (0.28–1.22) | 0.14 |
Other reason | 0.25 | (0.13–0.51) | <0.001 | 0.27 | (0.13–0.56) | <0.001 | 0.30 | (0.14–0.63) | 0.001 |
History of birth weight < 1500 g or preterm delivery | 1.63 | (0.82–3.73) | 0.20 | 1.67 | (0.82–3.85) | 0.19 | 1.77 | (0.86–4.14) | 0.15 |
Type of requesting maternity hospital | |||||||||
I | - | - | - | - | - | - | |||
IIA | 0.86 | (0.48–1.48) | 0.59 | 0.88 | (0.49–1.54) | 0.67 | 0.86 | (0.48–1.51) | 0.62 |
IIB | 0.67 | (0.38–1.12) | 0.14 | 0.72 | (0.41–1.23) | 0.24 | 0.71 | (0.40–1.21) | 0.22 |
III | 0.27 | (0.13–0.56) | <0.001 | 0.26 | (0.12–0.53) | <0.001 | 0.27 | (0.13–0.55) | <0.001 |
Tocolysis | 1.60 | (1.12–2.30) | 0.01 | 1.68 | (0.99–2.83) | 0.05 | |||
Cervical cerclage during the current pregnancy | 0.48 | (0.22–1.16) | 0.08 | 0.43 | (0.19–1.07) | 0.05 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vivanti, A.J.; Fesquet, S.; Gabriel, D.; Letourneau, A.; Crenn-Hebert, C.; De Luca, D.; Bouyer, J.; Novelli, S.; Benachi, A.; Veil, R. Impact of the 1st Wave of the COVID-19 Pandemic and Lockdown on In Utero Transfer Activity in the Paris Area, France. J. Clin. Med. 2022, 11, 4850. https://doi.org/10.3390/jcm11164850
Vivanti AJ, Fesquet S, Gabriel D, Letourneau A, Crenn-Hebert C, De Luca D, Bouyer J, Novelli S, Benachi A, Veil R. Impact of the 1st Wave of the COVID-19 Pandemic and Lockdown on In Utero Transfer Activity in the Paris Area, France. Journal of Clinical Medicine. 2022; 11(16):4850. https://doi.org/10.3390/jcm11164850
Chicago/Turabian StyleVivanti, Alexandre J., Stanislas Fesquet, Diane Gabriel, Alexandra Letourneau, Catherine Crenn-Hebert, Daniele De Luca, Jean Bouyer, Sophie Novelli, Alexandra Benachi, and Raphaël Veil. 2022. "Impact of the 1st Wave of the COVID-19 Pandemic and Lockdown on In Utero Transfer Activity in the Paris Area, France" Journal of Clinical Medicine 11, no. 16: 4850. https://doi.org/10.3390/jcm11164850
APA StyleVivanti, A. J., Fesquet, S., Gabriel, D., Letourneau, A., Crenn-Hebert, C., De Luca, D., Bouyer, J., Novelli, S., Benachi, A., & Veil, R. (2022). Impact of the 1st Wave of the COVID-19 Pandemic and Lockdown on In Utero Transfer Activity in the Paris Area, France. Journal of Clinical Medicine, 11(16), 4850. https://doi.org/10.3390/jcm11164850